Covered recipient · General Payments record
NATHAN PIRAKITIKULR
Allopathic & Osteopathic Physicians Ophthalmology Ophthalmic Plastic and Reconstructive Surgery
General Payments · PY2018–2024
$3,475.82
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,394.78 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $577.86 | 9 |
| ABBVIE INC. | $328.15 | 4 |
| Sight Sciences, Inc. | $306.59 | 3 |
| ARGENX US, INC. | $150.48 | 1 |
| MERZ NORTH AMERICA, INC. | $31.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $100.68 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105274850 | CMS |
| ABBVIE INC. | $126.76 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105274855 | CMS |
| ABBVIE INC. | $32.83 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105274859 | CMS |
| ABBVIE INC. | $67.88 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105274862 | CMS |
| Amgen Inc. | $31.48 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116020804 | CMS |
| Amgen Inc. | $141.42 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116020832 | CMS |
| Amgen Inc. | $28.20 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116020812 | CMS |
| Amgen Inc. | $157.35 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116020818 | CMS |
| Amgen Inc. | $4.32 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116020825 | CMS |
| Amgen Inc. | $23.71 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116020838 | CMS |
| Amgen Inc. | $142.23 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116020858 | CMS |
| Amgen Inc. | $12.88 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116020846 | CMS |
| Amgen Inc. | $36.27 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116020852 | CMS |
| ARGENX US, INC. | $150.48 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142123907 | CMS |
| MERZ NORTH AMERICA, INC. | $31.70 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146373678 | CMS |
| Sight Sciences, Inc. | $100.61 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151929343 | CMS |
| Sight Sciences, Inc. | $120.00 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151929345 | CMS |
| Sight Sciences, Inc. | $85.98 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151929341 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.